Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 11.30
+0.05 (0.44%)
Dec 5, 2025, 4:35 PM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 50.20 million as of December 5, 2025. Its market cap has increased by 52.05% in one year.
Market Cap
50.20M
Enterprise Value
47.52M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.30
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 50.20M, a decrease of -55.52%. That is a compound annual growth rate of -18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 50.20M | 41.19% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.56B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |